CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Flurazepam Hydrochloride Capsule
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2022-08-03. Latest FDA row update: 2026-09-15.
FDA lists 6 package records, with companies: Chartwell Molecular Holdings LLC, Chartwell RX, LLC, Rising Pharma Holdings, Inc.. Package NDCs: 0378-4415-01, 0378-4430-01, 62135-736-30, 62135-736-90, 62135-737-30, 62135-737-90.
FDA shortage reason: Regulatory delay
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Chartwell Molecular Holdings LLC | 62135-736-30 | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Available | 2026-09-15 |
| Chartwell Molecular Holdings LLC | 62135-736-90 | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Available | 2026-09-15 |
| Chartwell Molecular Holdings LLC | 62135-737-30 | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Available | 2026-09-15 |
| Chartwell Molecular Holdings LLC | 62135-737-90 | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Available | 2026-09-15 |
| Rising Pharma Holdings, Inc. | 0378-4415-01 | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) | Unavailable | 2026-09-01 |
| Rising Pharma Holdings, Inc. | 0378-4430-01 | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) | Unavailable | 2026-09-01 |
Source facts
Grouped generic ingredient: Flurazepam Hydrochloride Capsule · 6 package records
Therapeutic categories: Neurology, Oncology, Other
Dosage forms: Capsule
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.